# Innovation Corps supporting BoostOne SBIR

> **NIH NIH R43** · NXTECH INC · 2022 · $55,000

## Abstract

Project Summary
Individuals with opioid use disorder (OUD) face both short-term and long-term challenges to
healthy and productive decision-making. While recovery success is deeply affected by
phasic/psychological propensity for re-use, current strategies for cravings control suffer from
limited usability and restricted utility. The proposed innovation (“BoostONE”) comprises a
proprietary software-delivered method for just-in-time management of such risk events, as a
supplement to standard medication assisted treatment for OUD. Aims include platform
refinement and a real-world feasibility study. We anticipate this Phase I SBIR will provide the
foundation for deployment of BoostONE in active treatment settings and for broader extensions
of the underlying novel technology framework.

## Key facts

- **NIH application ID:** 10541738
- **Project number:** 3R43DA051270-01A1S1
- **Recipient organization:** NXTECH INC
- **Principal Investigator:** Salil Patel
- **Activity code:** R43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $55,000
- **Award type:** 3
- **Project period:** 2021-07-15 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10541738

## Citation

> US National Institutes of Health, RePORTER application 10541738, Innovation Corps supporting BoostOne SBIR (3R43DA051270-01A1S1). Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/grant/nih/10541738. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*